|
Global Medical REIT, Inc.
Ticker Symbol: GMRE CUSIP: 37954A303 Previous CUSIP: 37954A204 Exchange: NYSE
Company's Online Profile
BUSINESS: Global Medical REIT, Inc. focuses on operating as a real estate investment trust (REIT) that is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers. Its tenant-operators are physician group tenant-operators, community hospital tenant-operators and corporate medical treatment chain operators.
|
Find All Related Securities for GMRE
Notes: September 18, 2025 -- Global Medical REIT Inc. (the “Company”), the Company filed Articles of Amendment to its charter (the “Amendment”) with the Maryland State Department of Assessments and Taxation. The Amendment, effective as of 5:00 p.m. Eastern Time on September 19, 2025 (the “Effective Time”), converted every five shares of the issued and outstanding Common Stock into one share of common stock of the Company, par value $0.005 per share. The Reverse Stock Split also effected a proportionate reduction in the Company’s authorized shares of Common Stock from 500,000,000 shares to 100,000,000. The Common Stock will begin trading on a reverse split-adjusted basis on the New York Stock Exchange (the “NYSE”) at the opening of trading on September 22, 2025. The Common Stock will continue trading on the NYSE under the symbol “GMRE” with a new CUSIP number (37954A303).
|
IPO - 6/28/2016 - 13.00 Million Shares @ $10.00/share.
Link to IPO Prospectus
Mid Cap Stock -
Market Value $ Million
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 7373 Wisconsin Avenue, Suite 800,, Bethesda, MD 20814 |
| Main Phone Number |
202-524-6851 |
| Fax Number |
Not Available |
| Investor Relations
Evelyn Infurna, ICR Inc.
|
202-524-6869
|
| CEO - Mark Decker, Jr. |
CFO - Robert J. Kiernan |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
